Malaria Research Today is a free monthly online journal that collates and summarizes the latest research about Malaria, including details on prevention, treatment, causes, mosquitoes.

Volume 2 (2005), Issue 8 (August)

1. Traditional antimalarials and the development of novel antimalarial drugs.
   J Ethnopharmacol, 100(1): 67-71. [Abstract] [Full-text]
2. Plasmodium cynomolgi: gametocytocidal activity of the anti-malarial compound CDRI 80/53 (elubaquine) in rhesus monkeys.
   Exp Parasitol, 111(1): 8-13. [Abstract] [Full-text]
3. Plasmodium berghei NK65: studies on the effect of treatment duration and inoculum size on recrudescence.
   Exp Parasitol, 111(1): 59-63. [Abstract] [Full-text]
4. Reduced variation around drug-resistant dhfr alleles in African Plasmodium falciparum.
   Mol Biol Evol, 22(9): 1834-44. [Abstract] [Full-text]
5. An anti-Chitinase malaria transmission-blocking single-chain antibody as an effector molecule for creating a Plasmodium falciparum-refractory mosquito.
   J Infect Dis, 192(5): 878-87. [Abstract] [Full-text]
6. Genetic diversity of Plasmodium falciparum histidine-rich protein 2 (PfHRP2) and its effect on the performance of PfHRP2-based rapid diagnostic tests.
   J Infect Dis, 192(5): 870-7. [Abstract] [Full-text]
7. Antibodies to rhoptry-associated membrane antigen predict resistance to Plasmodium falciparum.
   J Infect Dis, 192(5): 861-9. [Abstract] [Full-text]
8. Evidence that interferon-gamma plays a protective role during cerebral malaria.
   J Infect Dis, 192(5): 854-60. [Abstract] [Full-text]
9. A randomized comparison of artesunate-atovaquone-proguanil versus quinine in treatment for uncomplicated falciparum malaria during pregnancy.
   J Infect Dis, 192(5): 846-53. [Abstract] [Full-text]
10. Comparison of axillary, rectal and tympanic temperature measurements in children admitted with malaria.
    J Trop Pediatr, 51(4): 242-4. [Abstract] [Full-text]
11. Prevalence of congenital malaria in Ile-ife, Nigeria.
    J Trop Pediatr, 51(4): 219-22. [Abstract] [Full-text]
12. The immune status of Kupffer cells profoundly influences their responses to infectious Plasmodium berghei sporozoites.
    Eur J Immunol, 35(8): 2335-46. [Abstract] [Full-text]
13. Documented cases of post-transfusion malaria occurring in England: a review in relation to current and proposed donor-selection guidelines.
    Vox Sang, 89(2): 77-80. [Abstract] [Full-text]
14. Malaria in pregnancy.
    BJOG, 112(9): 1189-95. [Abstract] [Full-text]
15. IL-4 receptor expression on CD8+ T cells is required for the development of protective memory responses against liver stages of malaria parasites.
    J Exp Med, 202(4): 551-60. [Abstract] [Full-text]
16. Targeting malaria parasite proteins to the erythrocyte.
    Trends Parasitol, 21(9): 399-402. [Abstract] [Full-text]
17. Systems biology in malaria research.
    Trends Parasitol, 21(9): 393-5. [Abstract] [Full-text]
18. Plasmodium parasite proteins and the infected erythrocyte.
    Trends Parasitol, 21(9): 402-3. [Abstract] [Full-text]
19. Revisiting Freund's incomplete adjuvant for vaccines in the developing world.
    Trends Parasitol, 21(9): 412-4. [Abstract] [Full-text]
20. Nitric oxide bioavailability in malaria.
    Trends Parasitol, 21(9): 415-22. [Abstract] [Full-text]
21. Cell-mediated effector molecules and complicated malaria.
    Int Arch Allergy Immunol, 137(4): 326-42. [Abstract] [Full-text]
22. Plasmodium falciparum antigenic variation: relationships between in vivo selection, acquired antibody response, and disease severity.
    J Infect Dis, 192(6): 1119-26. [Abstract] [Full-text]
23. Effects of HIV-1 serostatus, HIV-1 RNA concentration, and CD4 cell count on the incidence of malaria infection in a cohort of adults in rural Malawi.
    J Infect Dis, 192(6): 984-91. [Abstract] [Full-text]
24. Genome-wide expression profiling in malaria infection reveals transcriptional changes associated with lethal and nonlethal outcomes.
    Infect Immun, 73(9): 6091-100. [Abstract] [Full-text]
25. Merozoite surface protein 1 of Plasmodium vivax induces a protective response against Plasmodium cynomolgi challenge in rhesus monkeys.
    Infect Immun, 73(9): 5936-44. [Abstract] [Full-text]
26. Placental malaria induces variant-specific antibodies of the cytophilic subtypes immunoglobulin G1 (IgG1) and IgG3 that correlate with adhesion inhibitory activity.
    Infect Immun, 73(9): 5903-7. [Abstract] [Full-text]
27. Fetuin-A, a hepatocyte-specific protein that binds Plasmodium berghei thrombospondin-related adhesive protein: a potential role in infectivity.
    Infect Immun, 73(9): 5883-91. [Abstract] [Full-text]
28. HLA-A2 supertype-restricted cell-mediated immunity by peripheral blood mononuclear cells derived from Malian children with severe or uncomplicated Plasmodium falciparum malaria and healthy controls.
    Infect Immun, 73(9): 5799-808. [Abstract] [Full-text]
29. Early cytokine production is associated with protection from murine cerebral malaria.
    Infect Immun, 73(9): 5645-53. [Abstract] [Full-text]
30. Malaria-specific transgenic CD4(+) T cells protect immunodeficient mice from lethal infection and demonstrate requirement for a protective threshold of antibody production for parasite clearance.
    Blood, 106(5): 1676-84. [Abstract] [Full-text]
31. Clinical and molecular aspects of severe malaria.
    An Acad Bras Cienc, 77(3): 455-75. [Abstract] [Full-text]
32. Health risks and benefits of bis(4-chlorophenyl)-1,1,1-trichloroethane (DDT).
    Lancet, 366(9487): 763-73. [Abstract] [Full-text]
33. Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial.
    Lancet, 366(9487): 717-25. [Abstract] [Full-text]
34. Antimalarial compounds from Kniphofia foliosa roots.
    Phytother Res, 19(6): 472-6. [Abstract] [Full-text]
35. Artemisinin-based combination therapies (ACTs): best hope for malaria treatment but inaccessible to the needy!
    Acta Trop, 95(3): 305-15. [Abstract] [Full-text]
36. The impact of development and malaria control activities on its vectors in the Kinabatangan area of Sabah, East Malaysia.
    Acta Trop, 96(1): 24-30. [Abstract] [Full-text]
37. Variation in the relationship between anti-MSP-1(19) antibody response and age in children infected with Plasmodium falciparum during the dry and rainy seasons.
    Acta Trop, 95(3): 233-47. [Abstract] [Full-text]
38. Comparative efficacy of antimalarial drugs including ACTs in the treatment of uncomplicated malaria among children under 5 years in Ghana.
    Acta Trop, 95(3): 194-203. [Abstract] [Full-text]
39. Should chloroquine be laid to rest?
    Acta Trop, 96(1): 16-23. [Abstract] [Full-text]
40. Ethical perspective on malaria research for Africa.
    Acta Trop, 95(3): 276-84. [Abstract] [Full-text]
41. Polymorphisms in Plasmodium falciparum dhfr and dhps genes and age related in vivo sulfadoxine-pyrimethamine resistance in malaria-infected patients from Nigeria.
    Acta Trop, 95(3): 183-93. [Abstract] [Full-text]
42. Genetic diversity of the msp-1 locus and symptomatic malaria in south-west Nigeria.
    Acta Trop, 95(3): 226-32. [Abstract] [Full-text]
43. Advances in malaria genomics since MIM Arusha, 2002.
    Acta Trop, 95(3): 260-4. [Abstract] [Full-text]
44. Rapid increase in resistance of Plasmodium falciparum to chloroquine-Fansidar in Uganda and the potential of amodiaquine-Fansidar as a better alternative.
    Acta Trop, 95(3): 172-82. [Abstract] [Full-text]
45. Naturally acquired immunity to Plasmodium falciparum malaria in Africa.
    Acta Trop, 95(3): 270-5. [Abstract] [Full-text]
46. Social science research in malaria prevention, management and control in the last two decades: an overview.
    Acta Trop, 95(3): 292-7. [Abstract] [Full-text]
47. Anopheles infection responses; laboratory models versus field malaria transmission systems.
    Acta Trop, 95(3): 285-91. [Abstract] [Full-text]
48. Plasmodium falciparum malaria in south-west Nigerian children: is the polymorphism of ICAM-1 and E-selectin genes contributing to the clinical severity of malaria?
    Acta Trop, 95(3): 248-55. [Abstract] [Full-text]
49. In vivo chloroquine resistance and prevalence of the pfcrt codon 76 mutation in Plasmodium falciparum isolates from the Republic of Congo.
    Acta Trop, 95(3): 219-25. [Abstract] [Full-text]
50. Epidemiology and surveillance: changing the global picture of malaria--myth or reality?
    Acta Trop, 95(3): 265-9. [Abstract] [Full-text]
51. Malaria vaccines. Evaluation and implementation.
    Acta Trop, 95(3): 298-304. [Abstract] [Full-text]
52. Adaptation to past malarial endemia and susceptibility to common diseases in modern populations: a study of adenosine deaminase and MN blood group genetic polymorphisms.
    Am J Phys Anthropol, 128(1): 194-8. [Abstract] [Full-text]
53. Questionnaire-based analysis of mefloquine chemoprophylaxis for malaria in a Japanese population.
    J Infect Chemother, 11(4): 196-8. [Abstract] [Full-text]
54. In vivo and in vitro analysis of chloroquine resistance in Plasmodium falciparum isolates from Senegal.
    Parasitol Res, 97(2): 136-40. [Abstract] [Full-text]

© 2004-2008 Malaria Research Today. All Rights Reserved.